AU3783497A - Metabotropic glutamate receptor agonists - Google Patents

Metabotropic glutamate receptor agonists

Info

Publication number
AU3783497A
AU3783497A AU37834/97A AU3783497A AU3783497A AU 3783497 A AU3783497 A AU 3783497A AU 37834/97 A AU37834/97 A AU 37834/97A AU 3783497 A AU3783497 A AU 3783497A AU 3783497 A AU3783497 A AU 3783497A
Authority
AU
Australia
Prior art keywords
receptor agonists
glutamate receptor
metabotropic glutamate
metabotropic
agonists
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU37834/97A
Inventor
Satoshi Hayashibe
Hirotsune Itahana
Masamichi Okada
Shinichi Tsukamoto
Kiyoshi Yahiro
Hiroshi Yamashita
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Yamanouchi Pharmaceutical Co Ltd
Original Assignee
Yamanouchi Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Yamanouchi Pharmaceutical Co Ltd filed Critical Yamanouchi Pharmaceutical Co Ltd
Publication of AU3783497A publication Critical patent/AU3783497A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/429—Thiazoles condensed with heterocyclic ring systems

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU37834/97A 1996-08-09 1997-08-07 Metabotropic glutamate receptor agonists Abandoned AU3783497A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP21127896 1996-08-09
JP8-211278 1996-08-09
PCT/JP1997/002748 WO1998006724A1 (en) 1996-08-09 1997-08-07 Metabotropic glutamate receptor agonists

Publications (1)

Publication Number Publication Date
AU3783497A true AU3783497A (en) 1998-03-06

Family

ID=16603285

Family Applications (1)

Application Number Title Priority Date Filing Date
AU37834/97A Abandoned AU3783497A (en) 1996-08-09 1997-08-07 Metabotropic glutamate receptor agonists

Country Status (3)

Country Link
AU (1) AU3783497A (en)
ID (1) ID18708A (en)
WO (1) WO1998006724A1 (en)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0891978B1 (en) * 1997-07-18 2002-03-20 F. Hoffmann-La Roche Ag 5H-Thiazolo (3,2-a) pyrimidine derivatives
US6455283B1 (en) 1998-03-17 2002-09-24 Genentech, Inc. Nucleic acids encoding vascular endothelial cell growth factor-E (VEGF-E)
WO1999044639A1 (en) * 1998-03-03 1999-09-10 Yamanouchi Pharmaceutical Co., Ltd. Remedies for brain infarction
AU2241400A (en) 1999-04-06 2000-10-12 Yamanouchi Pharmaceutical Co., Ltd. Novel thiazolobenzoimidazole derivative
DE19948434A1 (en) * 1999-10-08 2001-06-07 Gruenenthal Gmbh Substance library containing bicyclic imidazo-5-amines and / or bicyclic imidazo-3-amines
WO2002062803A1 (en) * 2001-02-08 2002-08-15 Yamanouchi Pharmaceutical Co., Ltd. Thienopyrimidine derivative
AR059898A1 (en) 2006-03-15 2008-05-07 Janssen Pharmaceutica Nv DERIVATIVES OF 3-CIANO-PIRIDONA 1,4-DISUSTITUTED AND ITS USE AS ALLOSTERIC MODULATORS OF MGLUR2 RECEIVERS
CN101448843B (en) 2006-03-17 2012-05-09 埃姆比特生物科学公司 Imidazolothiazole compounds for the treatment of disease
EP2578216A1 (en) 2006-11-22 2013-04-10 Seaside Therapeutics, Inc. Methods of treating fragile x syndrome
TW200845978A (en) 2007-03-07 2008-12-01 Janssen Pharmaceutica Nv 3-cyano-4-(4-tetrahydropyran-phenyl)-pyridin-2-one derivatives
TW200900065A (en) 2007-03-07 2009-01-01 Janssen Pharmaceutica Nv 3-cyano-4-(4-pyridinyloxy-phenyl)-pyridin-2-one derivatives
BRPI0816767B8 (en) 2007-09-14 2021-05-25 Addex Pharmaceuticals Sa compound 4-phenyl-3,4,5,6-tetrahydro-2h,1'h-[1,4']bipyridinyl-2'-disubstituted 1',3'-ones, pharmaceutical composition and use of same
US8883783B2 (en) 2007-09-19 2014-11-11 Ambit Biosciences Corporation Solid forms comprising N-(5-tert-butyl-isoxazol-3-yl)-N′-{4-[7-(2-morpholin-4-yl-ethoxy)imidazo[2,1-b][1,3]benzothiazol-2-yl]phenyl}urea, compositions thereof, and uses therewith
ES2439291T3 (en) 2008-09-02 2014-01-22 Janssen Pharmaceuticals, Inc. 3-Azabicyclo [3.1.0] hexyl derivatives as modulators of metabotropic glutamate receptors
WO2010060589A1 (en) 2008-11-28 2010-06-03 Ortho-Mcneil-Janssen Pharmaceuticals, Inc. Indole and benzoxazine derivatives as modulators of metabotropic glutamate receptors
EP2218464A1 (en) * 2009-02-11 2010-08-18 Technische Universität München Compounds for non-invasive measurement of aggregates of amyloid peptides
NZ596053A (en) 2009-05-12 2013-05-31 Janssen Pharmaceuticals Inc 1,2,4-triazolo[4,3-a]pyridine derivatives and their use as positive allosteric modulators of mglur2 receptors
CN102439008B (en) 2009-05-12 2015-04-29 杨森制药有限公司 1,2,3-triazolo [4,3-a] pyridine derivatives and their use for the treatment or prevention of neurological and psychiatric disorders
MY153913A (en) 2009-05-12 2015-04-15 Janssen Pharmaceuticals Inc 7-aryl-1,2,4-triazolo[4,3-a]pyridine derivatives and their use as positive allosteric modulators of mglur2 receptors
KR101819245B1 (en) * 2009-11-05 2018-01-16 암비트 바이오사이언시즈 코포레이션 Process for the preparation of imidazo[2,1-b][1,3]benzothiazole derivatives
WO2011109398A2 (en) 2010-03-02 2011-09-09 President And Fellows Of Harvard College Methods and compositions for treatment of angelman syndrome and autism spectrum disorders
US20110294879A1 (en) 2010-05-28 2011-12-01 Xenoport, Inc. Method of treatment of fragile x syndrome, down's syndrome, autism and related disorders
WO2012009646A1 (en) 2010-07-15 2012-01-19 Xenoport, Inc. Methods of treating fragile x syndrome, down's syndrome, autism and related disorders
US8993591B2 (en) 2010-11-08 2015-03-31 Janssen Pharmaceuticals, Inc. 1,2,4-triazolo[4,3-a] pyridine derivatives and their use as positive allosteric modulators of MGLUR2 receptors
ES2536433T3 (en) 2010-11-08 2015-05-25 Janssen Pharmaceuticals, Inc. 1,2,4-Triazolo [4,3-a] pyridine derivatives and their use as positive allosteric modulators of mGluR2 receptors
US9271967B2 (en) 2010-11-08 2016-03-01 Janssen Pharmaceuticals, Inc. 1,2,4-triazolo[4,3-a]pyridine derivatives and their use as positive allosteric modulators of mGluR2 receptors
JO3368B1 (en) 2013-06-04 2019-03-13 Janssen Pharmaceutica Nv 6,7-DIHYDROPYRAZOLO[1,5-a]PYRAZIN-4(5H)-ONE COMPOUNDS AND THEIR USE AS NEGATIVE ALLOSTERIC MODULATORS OF MGLUR2 RECEPTORS
JO3367B1 (en) 2013-09-06 2019-03-13 Janssen Pharmaceutica Nv 1,2,4-TRIAZOLO[4,3-a]PYRIDINE COMPOUNDS AND THEIR USE AS POSITIVE ALLOSTERIC MODULATORS OF MGLUR2 RECEPTORS
DK3096790T3 (en) 2014-01-21 2019-10-07 Janssen Pharmaceutica Nv COMBINATIONS INCLUDING POSITIVE ALLOSTERIC MODULATORS OR ORTHOSTERIC AGONISTS OF METABOTROP GLUTAMATERG SUBTYPE 2 RECEPTOR AND APPLICATION OF THESE
DK3431106T3 (en) 2014-01-21 2021-03-15 Janssen Pharmaceutica Nv COMBINATIONS INCLUDING POSITIVE ALLOSTERIC MODULATORS OR ORTHOSTERIC AGONISTS OF METABOTROP GLUTAMATERG SUBTYPE 2 RECEPTOR AND USE OF THESE
WO2019131656A1 (en) * 2017-12-28 2019-07-04 政一 親泊 Benzothiazoimidazolyl compound-containing agent for adjusting endoplasmic reticulum stress

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2463774A1 (en) * 1979-08-21 1981-02-27 Yamanouchi Pharma Co Ltd DERIVATIVES OF 2-PHENYLIMIDAZO (2,1-B) BENZOTHIAZOLE
JPS56138196A (en) * 1980-03-29 1981-10-28 Yamanouchi Pharmaceut Co Ltd Imidazo (2,1-b)benzothiazole derivative
JPS5740492A (en) * 1980-08-22 1982-03-06 Yamanouchi Pharmaceut Co Ltd Novel 2-phenylimidazo 2,1-b benzothiazole derivative
JPS57149288A (en) * 1981-03-12 1982-09-14 Yamanouchi Pharmaceut Co Ltd Imidazo(2,1-b)benzothiazole derivative
US4464384A (en) * 1981-12-23 1984-08-07 Yamanouchi Pharmaceutical Co., Ltd. 2-Phenylimidazo[2,1-b]benzothiazole compounds, salts thereof, process of producing them, and pharmaceutical compositions containing them
EP0524055A1 (en) * 1991-07-19 1993-01-20 Synthelabo Imidazo(2,1-b)benzothiazole-3-acetamide derivatives, process for their preparation and their therapeutical use
FR2699920B1 (en) * 1992-12-24 1995-02-10 Synthelabo Imidazo [2,1-b] benzothiazole-3-acetamide derivatives, their preparation and their therapeutic use.
FR2699921B1 (en) * 1992-12-30 1995-02-10 Synthelabo 2- (Thien-2-yl) imidazo [2,1-b] benzothiazole-3-acetic acid derivatives, their preparation and their therapeutic use.
IL112957A0 (en) * 1994-03-14 1995-06-29 Novo Nordisk As Thieno [2,3-b] indoles, their preparation and pharmaceutical compositions containing them

Also Published As

Publication number Publication date
WO1998006724A1 (en) 1998-02-19
ID18708A (en) 1998-04-30

Similar Documents

Publication Publication Date Title
AU3783497A (en) Metabotropic glutamate receptor agonists
AU1052599A (en) Retinoid receptor agonists
AU5203999A (en) Beta3-adrenergic receptor agonists
AU5343298A (en) 5-ht2c receptor agonists and aminoalkylindazole derivatives
AU4091696A (en) Estrogen agonists/antagonists
AU7692996A (en) Receptor antagonists
AU2697897A (en) Indole derivatives useful as endothelin receptor antagonists
AU7295698A (en) An electrohydrodynamic receptor
AU3579897A (en) Fibrinogen receptor antagonists
AU3503797A (en) Fibrinogen receptor antagonist prodrugs
AU4797400A (en) Metabotropic glutamate receptor antagonists
AU3110095A (en) Glutamate receptor
AU1594697A (en) New substituted 19-nor-pregnane derivatives
AU7349298A (en) Prostaglandin agonists
AU5196996A (en) Adhesion receptor antagonists
AU1230795A (en) Adhesion receptor antagonists
AU7132898A (en) Edg-1-like receptor
AU5506896A (en) Human p2x4 receptor splice-variants
AU6450196A (en) Hr-1 receptor
AU6748196A (en) Receptor
AU1550195A (en) G-protein coupled receptor
AU2961097A (en) Substituted pyrazolylpyrazole derivatives
AU6175696A (en) Hr-1 receptor
AU1535699A (en) Novel receptors opg-2
AU3339697A (en) Indoline derivatives useful as 5-ht-2c receptor antagonists